Abstract:Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by high blood glucose levels resulting from insulin resistance and impaired insulin secretion. Immune dysregulation-mediated chronic low-grade inflammation is a critical factor that poses a significant risk to the metabolic disorders of T2DM and its related complications. Exosomes, as small extracellular vesicles secreted by various cells, have emerged as essential regulators of intercellular communication and immune regulation. In this review, we summarize the current understanding of the role of exosomes derived from immune and nonimmune cells in modulating immune responses in T2DM by regulating immune cell functions and cytokine production. More importantly, we suggest potential strategies for the clinical applications of exosomes in T2DM management, including biomarkers for disease diagnosis and monitoring, exosome-based therapies for drug delivery vehicles, and targeted therapy for exosomes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of exosomes as emerging immunomodulatory factors in type 2 diabetes mellitus (T2DM). Specifically, the paper focuses on the following aspects: 1. **The role of exosomes in T2DM**: - Exosomes are small extracellular vesicles secreted by various cells and play an important role in intercellular communication and immunomodulation. - The paper summarizes the current understanding of how exosomes regulate the immune response in T2DM by modulating immune cell function and cytokine production. 2. **The role of the immune system in T2DM**: - Chronic low - grade inflammation mediated by immune dysregulation is an important risk factor for T2DM and its associated complications. - The paper discusses in detail the complex role of the immune system in the pathogenesis of T2DM, especially how immune cells affect insulin resistance and β - cell dysfunction through exosomes. 3. **The origin and characteristics of exosomes**: - The paper introduces the biogenesis process, release mechanism, as well as their composition and function of exosomes. - It particularly emphasizes the different roles of exosomes from immune cells and non - immune cells (such as adipose tissue and pancreatic β - cells) in T2DM. 4. **Clinical applications**: - The paper explores the potential clinical applications of exosomes in T2DM management, including: - **Disease diagnosis and monitoring**: Exosomes can be used as biomarkers for the early diagnosis of T2DM and the monitoring of disease progression. - **Exosome - based therapy**: Exosomes can be used to develop new treatment methods, for example, by delivering drugs or siRNA to regulate the immune response. - **Drug - delivery carriers**: Exosomes, due to their good biocompatibility and targeting ability, can be used as drug - delivery carriers, especially in metabolism - related neurological diseases. In conclusion, this paper aims to comprehensively summarize the immunomodulatory role of exosomes in T2DM and explore their potential applications in clinical diagnosis and treatment. This provides an important theoretical basis and practical guidance for future research and treatment strategies.

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus